Mammaglobin B (MGB2) and mammaglobin A (MGB1) are proteins expressed in metastatic breast cancers. The early detection of circulating tumor cells (CTCs) in breast cancer patients is crucial to decrease mortality rate. Herein, novel aptamers were successfully selected and characterized against MGB2 and MGB1 proteins using a hybrid SELEX approach. The potential use of the selected aptamers in breast CTC detection was studied using spiked breast cancer cells in whole blood lysate. The results obtained from this study showed that the selected aptamers (MAMB1 and MAMA2) bind to their target breast cancer cell lines with high affinity (low nanomolar Kd values) and specificity. They also bind to their free recombinant target proteins and show minimal non-specific binding to normal and other cancer cell lines. Additionally, they were able to distinguish a low number of breast cancer cells spiked in whole blood lysate containing normal blood cells. The results obtained in this study indicate the great potential for the use of aptamers to detect MGB1 and MGB2 protein biomarkers, expressed on the surface of breast CTCs.

Additional Metadata
Persistent URL dx.doi.org/10.1038/s41598-017-13751-z
Journal Scientific Reports
Citation
Hassan, E.M. (Eman M.), Willmore, W.G. (William G.), McKay, B, & DeRosa, M.C. (2017). In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells. Scientific Reports, 7(1). doi:10.1038/s41598-017-13751-z